A true inspiration to all who learn.
Encourages open-minded and thoughtful discussions.
This comment is not public.
Professor Natasha Lannin is an internationally recognised clinician-researcher and occupational therapist with a joint appointment at Alfred Health and Monash University, where she serves as Professor in the Department of Neuroscience, School of Translational Medicine, and Head of the Brain Recovery and Rehabilitation Research Group. Her research specializations encompass neurorehabilitation after stroke and traumatic brain injury, with a focus on translational studies targeting brain recovery mechanisms, non-pharmacological interventions, neurotechnological approaches, and complex clinical trials from phase II to IV. Key interests include motor and cognitive recovery, fall prevention, vocational rehabilitation, guideline implementation, and quality of care in rehabilitation settings. She leads projects such as the VocRehab Trial for early return-to-work after stroke, PROMOTE Trial for upper limb rehabilitation guidelines, CHAT Trial for aphasia treatment, and HOME Rehab Trial for pre-discharge home assessments.
Lannin holds a Bachelor of Science in Occupational Therapy from Curtin University, Graduate Diploma in Case Management from the University of Melbourne, PhD in Neuroscience from Western Sydney University awarded in 2006 for her thesis on the effectiveness of hand splinting to prevent muscle contracture following acquired brain impairment, and Graduate Certificate in Implementation Science from the University of California System. Her career trajectory includes postdoctoral work advancing clinical trials at the University of Sydney Faculty of Medicine, serving as inaugural Chair in Occupational Therapy at La Trobe University in joint position with Alfred Health from 2011 to 2019, and joining Monash University in 2019. With over 320 peer-reviewed publications and career grants exceeding $60 million, including NHMRC Translating Research into Practice Fellowship (2016), NHMRC Career Development Fellowship (2018), Heart Foundation Future Leader Fellowship Level 3 (2023-2026), Fellowship of the American Occupational Therapy Foundation Academy of Research (2017), Fellowship of Occupational Therapy Australia Research Academy (2017), Excellence in Mid-Career Research Award (2018), Australian Clinical Trials Alliance Consumer Involvement Award (2024 shared), and Ignite Award (2025), she ranks in the top 1% worldwide for neurological rehabilitation and occupational therapy expertise, significantly influencing evidence-based clinical practice and policy in neurorehabilitation.
